Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Orphan Star Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Orphan Star Therapeutics

Orphan Star Therapeutics

Orphan Star Therapeutics: A NY-based biopharmaceutical firm developing therapies for rare diseases.

HQ
New York City, NY, US
Founded
2017
Overview
Compare
Fundraising
Employees

Orphan Star Therapeutics is a biopharmaceutical company dedicated to developing therapies for rare diseases, including Canavan disease and genetic neurodegenerative disorders. Based in New York, the company aims to address unmet medical needs in these specialized markets.

The company has made significant strides in its research and development efforts, contributing to advancements in the treatment of rare diseases. Its impact is recognized within the biopharmaceutical industry, particularly in the niche of genetic neurodegenerative conditions.

Orphan Star Therapeutics - Similar Companies

Star Therapeutics logo

Star Therapeutics

Orphion Therapeutics logo

Orphion Therapeutics

Orbus Therapeutics logo

Orbus Therapeutics

Advent Therapeutics logo

Advent Therapeutics

Ovid Therapeutics logo

Ovid Therapeutics

ovidrx.com

Astria Therapeutics logo

Astria Therapeutics

astriatx.com

River 3 Renal logo

River 3 Renal

Orion BioScience logo

Orion BioScience

Phoenicis logo

Phoenicis

Denali Therapeutics logo

Denali Therapeutics

Orphinic Scientific logo

Orphinic Scientific

orphinic.com

Mahzi Therapeutics logo

Mahzi Therapeutics

mahzi.com

Orbital Therapeutics logo

Orbital Therapeutics

GlobeStar Therapeutics logo

GlobeStar Therapeutics

AI Therapeutics logo

AI Therapeutics

Orphan Star Therapeutics - Quick Facts

Who are Orphan Star Therapeutics' competitors?

Companies similar to Orphan Star Therapeutics include Star Therapeutics, Orphion Therapeutics, Orbus Therapeutics and Advent Therapeutics.

When was Orphan Star Therapeutics founded?

Orphan Star Therapeutics was founded in 2017.

Where is Orphan Star Therapeutics' headquarters located?

Orphan Star Therapeutics' headquarters is located in New York City, NY, US.

When was Orphan Star Therapeutics' last funding round?

Orphan Star Therapeutics' most recent funding round was for $20M (USD) in September 2018.

How much has Orphan Star Therapeutics raised to-date?

As of Sep 26, 2018, Orphan Star Therapeutics has raised a total of $20M (USD).

How many employees does Orphan Star Therapeutics have?

Orphan Star Therapeutics has 5 employees as of Feb 4, 2024.

Orphan Star Therapeutics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Therapies
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified